Home > Food & Beverages > Food Additives > Flavor Enhancers > Psychedelic Mushroom Market

Psychedelic Mushroom Market Analysis

  • Report ID: GMI6886
  • Published Date: Oct 2023
  • Report Format: PDF

Psychedelic Mushroom Market Analysis

Based on product, the psychedelic mushroom market from psilocybe segment dominated around USD 1.70 billion revenue in the year 2022, attributed to increasing research is shedding light on its efficacy in treating mental health conditions such as depression, anxiety, and post-traumatic stress disorder, making it a focus of scientific and medical attention. Furthermore, the growing demand for alternative and holistic approaches to healthcare, coupled with a mental health crisis exacerbated by the COVID-19 pandemic, has elevated the profile of Psilocybe as a potential solution.
 

Psychedelic Mushroom Market Revenue Share, By Form, (2022)

Based on form, the psychedelic mushroom market from fresh and whole segment to observe 10.3% CAGR during the forecast timeline. As consumers increasingly prioritize natural, unprocessed, and organic food options for health and wellness, this preference extends to the cultivation and use of psychedelic mushrooms. Freshly harvested and whole mushrooms are valued for their purity and potency, offering a more authentic and unadulterated psychedelic experience.
 

Psychedelic Mushroom Market Revenue Share, By Application, (2022)

Based on application, de-addiction segment is set to show tremendous growth through 2032, due to a compelling shift in perspective on addiction treatment. Psychedelic mushrooms, specifically substances like psilocybin, have gained attention for their potential to address addiction issues. Research has shown promising results in using psychedelics to break the cycle of substance dependency, with users reporting profound and transformative experiences that lead to reduced cravings and long-term abstinence.
 

Asia Pacifc Psychedelic Mushroom Market Revenue, 2021 - 2032 (USD Billion)

The Asia Pacific psychedelic mushroom market is poised to register over 10.1% CAGR till 2032, owing to growing awareness and acceptance of the potential therapeutic benefits of psychedelics, including psilocybin mushrooms. As research continues to demonstrate their efficacy in treating mental health conditions such as depression, anxiety, and PTSD, there is a rising demand for these substances.
 

Furthermore, the Asia-Pacific region is home to a rich diversity of mushroom species, many of which contain psilocybin or related compounds. This has led to a surge in local cultivation and extraction efforts, as well as a burgeoning interest in traditional practices and rituals involving psychedelic mushrooms. Additionally, regulatory shifts in some parts of the Asia-Pacific have been relatively favorable, with countries like Thailand taking steps to decriminalize or regulate the use of psychedelic substances. This has created a more supportive environment for research, cultivation, and responsible consumption.

Authors: Kunal Ahuja, Himanshu Kabra

Frequently Asked Questions (FAQ) :

The market size of psychedelic mushroom reached USD 1.93 billion in 2022 and is set to expand at over 10.7% CAGR from 2023 to 2032, led by the ongoing research to discover the potential therapeutic benefits.

The psilocybe product segment generated USD 1.70 billion in revenue in 2022, attributed to ongoing research initiatives along with the growing demand for alternative and holistic approaches to healthcare.

Asia Pacific market is projected to witness 10.1% CAGR through 2032, owing to the growing awareness and acceptance of the potential therapeutic benefits of psychedelics in the region.

Some of the leading psychedelic mushroom companies include Field Trip Health, Atai Life Sciences, Cybin Inc., Mydecine Innovations Group, Revive Therapeutics, and Numinus Wellness.

Psychedelic Mushroom Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 8
  • Tables & Figures: 264
  • Countries covered: 21
  • Pages: 180
 Download Free Sample